Home / Learn / Cancer Types / Lung Cancer / Operational Pathways for Molecular Testing in NSCLC / Biomarker Testing Implementation Roadmap for Advanced NSCLC

Biomarker Testing Implementation Roadmap for Advanced NSCLC

The Biomarker Testing Implementation Roadmap for Advanced Non-Small Cell Lung Cancer (NSCLC) is an innovative learning tool that can help multidisciplinary cancer care teams obtain the knowledge they need to implement, expand, and sustain biomarker testing for patients with advanced NSCLC. The Roadmap will give users information about how to lay the groundwork for biomarker testing, train and prepare their care team to offer testing, implement the testing, and evaluate ongoing progress. “Expert Insights” from the Advisory Committee that informed the Roadmap give teams a deeper understanding of how biomarker testing fits into their cancer program. Accompanying resources provide more information and are available in the Resource Library.

Sharing Article:

"This biomarker testing program is critical for provider and patients. For providers, this pathway will aid in being able to implement a high quality testing program in their institution. For patients, it will ensure they receive personalized, biomarker directed treatment where appropriate, which will improve their survival."

Gerard SilvestriGerard Silvestri, MD, MS
Professor of Medicine, Lung Cancer Pulmonologist
Medical University of South Carolina
Charleston, SC

Our Partners

amp-200x80 lungevity-200x80

Our Supporter

This project is sponsored by Amgen.